Education is critical for medication adherence in patients with coronary heart disease

Acta Cardiologica
|July 8, 2015
PubMed

Insights

Improving medication adherence in coronary heart disease (CHD) patients requires enhanced knowledge. Educating patients, particularly through pharmacists, can significantly improve adherence to medication instructions.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Education

Background:

  • Medication non-adherence in coronary heart disease (CHD) is linked to increased cardiovascular risks.
  • Limited research exists on the connection between knowledge and medication adherence in CHD patients.

Purpose of the Study:

  • To evaluate the relationship between medication adherence and knowledge in CHD patients.
  • To determine if patient education impacts medication adherence behavior.

Main Methods:

  • Assessed medication adherence using the Morisky Medication Adherence Scale (MMSA-8).
  • Measured medication- and disease-related knowledge with the Medication- or Disease-Related Knowledge Test (MDRKT).
  • Explored patient preferences for medication education and the role of pharmacists.

Main Results:

  • 38.4% of 159 CHD patients exhibited non-adherence (MMAS-8 score <6).
  • Lower knowledge and concerns about adverse drug events correlated with non-adherence.
  • Most participants (95.0%) desired medication education, with few identifying pharmacists as a primary information source.

Conclusions:

  • Greater knowledge correlates with better medication adherence in CHD patients.
  • Patients often struggle to obtain medication information, highlighting a need for accessible education.
  • Pharmacist-led education services are recommended to improve patient understanding and adherence.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
473
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
589
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
429